Results 31 to 40 of about 6,863,547 (308)

Testosterone and Cardiovascular Disease [PDF]

The Open Cardiovascular Medicine Journal, 2016
Cardiovascular disease [CVD] is a leading cause of mortality accounting for a global incidence of over 31%. Atherosclerosis is the primary pathophysiology underpinning most types of CVD. Historically, modifiable and non-modifiable risk factors were suggested to precipitate CVD.
Tambo, Amos, Roshan, Mohsin H.K., Pace, Nikolai Paul   +2 more
openaire   +3 more sources

Luteolin Pretreatment Ameliorates Myocardial Ischemia/Reperfusion Injury by lncRNA-JPX/miR-146b Axis

Analytical Cellular Pathology, 2023
Background. In the present study, we aimed to find out whether luteolin (Lut) pretreatment could ameliorate myocardial ischemia/reperfusion (I/R) injury by regulating the lncRNA just proximal to XIST (JPX)/microRNA-146b (miR-146b) axis. Methods.
Tongda Xu, Yuanyuan Zhang, Gege Liao, Haochen Xuan, Jie Yin, Jieli Bao, Yang Liu, Dongye Li   +7 more
doaj   +1 more source

Commentary : controversies in NICE guidance on lipid modification for the prevention of cardiovascular disease [PDF]

, 2008
The new guidelines from the National Institute for Health and Clinical Excellence (NICE) on lipid modification for the prevention of cardiovascular disease will guide the way we assess cardiovascular risk and treat lipids, both in primary and in ...
Cappuccio, Francesco
core   +1 more source

Lysophosphatidic Acid Is Associated With Cardiac Dysfunction and Hypertrophy by Suppressing Autophagy via the LPA3/AKT/mTOR Pathway

Frontiers in Physiology, 2018
Background: Lysophosphatidic acid (LPA), as a phospholipid signal molecule, participates in the regulation of various biological functions. Our previous study demonstrated that LPA induces cardiomyocyte hypertrophy in vitro; however, the functional role ...
Jinjing Yang, Jinjing Yang, Jinjing Yang, Jiyao Xu, Jiyao Xu, Xuebin Han, Xuebin Han, Hao Wang, Yuean Zhang, Yuean Zhang, Jin Dong, Jin Dong, Yongzhi Deng, Yongzhi Deng, Jingping Wang, Jingping Wang   +15 more
doaj   +1 more source

Orthostatic variation of pulmonary artery pressure in ambulatory heart failure patients

BMC Cardiovascular Disorders, 2023
Aim To study effect of change in position (supine and standing) on pulmonary artery pressure (PAP) in ambulatory heart failure (HF) patients. Methods Seventeen patients with CardioMEMS® sensor and stable heart failure were consented and included in this ...
Prince Sethi, Prakash Acharya, Payton Lancaster, Brianna Stack, Kartik Munshi, Sagar Ranka, Zubair Shah, Andrew J. Sauer, Kamal Gupta   +8 more
doaj   +1 more source

Lipoprotein(a) in Cardiovascular Diseases [PDF]

BioMed Research International, 2013
Lipoprotein(a) (Lp(a)) is an LDL-like molecule consisting of an apolipoprotein B-100 (apo(B-100)) particle attached by a disulphide bridge to apo(a). Many observations have pointed out that Lp(a) levels may be a risk factor for cardiovascular diseases.
Malaguarnera M, Vacante M, Russo C, Malaguarnera G, Antic T, MALAGUARNERA, Lucia, BELLA, Rita, PENNISI, Giovanni, GALVANO, Fabio, Frigiola A.   +9 more
openaire   +3 more sources

Who Has Seen Patients With ST‐Segment–Elevation Myocardial Infarction? First Results From Italian Real‐World Coronavirus Disease 2019

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
Background After the coronavirus disease 2019 outbreak, social isolation measures were introduced to contain infection. Although there is currently a slowing down of the infection, a reduction of hospitalizations, especially for myocardial infarction ...
Valeria Cammalleri, Saverio Muscoli, Daniela Benedetto, Giuseppe Stifano, Massimiliano Macrini, Alessio Di Landro, Marco Di Luozzo, Massimo Marchei, Enrica Giuliana Mariano, Linda Cota, Domenico Sergi, Andrea Bezzeccheri, Michela Bonanni, Martino Baluci, Pasquale De Vico, Francesco Romeo   +15 more
doaj   +1 more source

Gender-Related Differences in the Prevalence of Cardiovascular Disease Risk Factors and their Correlates in Urban Tanzania. [PDF]

, 2009
\ud Urban areas in Africa suffer a serious problem with dual burden of infectious diseases and emerging chronic diseases such as cardiovascular diseases (CVD) and diabetes which pose a serious threat to population health and health care resources ...
Mpembeni, Rose, Muhihi Alfa, Finkelstein, Julia, Spiegelman Donna, Mpembeni, R., Hertzmark, E., Spiegelman, D., Hertzmark Ellen, Muhihi, A., Njelekela, Marina A, Mligiliche Nuru L, Mligiliche, N.L., Willett Walter C, Fawzi, Wafaie, Spiegelman, Donna, Liu, Enju, Willett, W.C., Mligiliche, Nuru L, Njelekela, M.A., Willett, Walter C, Fawzi, W.W., Hertzmark, Ellen, Mpembeni Rose, Finkelstein, Julia L, Liu Enju, Fawzi Wafaie W, Mtabaji, Jacob, Njelekela Marina A, Mtabaji Jacob, Finkelstein, J.L., Willett, Walter, Fawzi, Wafaie W, Finkelstein Julia L, Mtabaji, J., Liu, E., Muhihi, Alfa   +35 more
core   +1 more source

Obesity and Cardiovascular Disease [PDF]

Circulation Research, 2016
The prevalence of obesity has increased worldwide over the past few decades. In 2013, the prevalence of obesity exceeded the 50% of the adult population in some countries from Oceania, North Africa, and Middle East. Lower but still alarmingly high prevalence was observed in North America (≈30%) and in Western Europe (≈20%). These figures are of serious
Ortega, Francisco B., Lavie, Carl J., Blair, Steven N.   +2 more
openaire   +5 more sources

Tetrahydrobiopterin and Cardiovascular Disease [PDF]

Arteriosclerosis, Thrombosis, and Vascular Biology, 2006
Tetrahydrobiopterin (BH 4 ) is an essential cofactor for the aromatic amino acid hydroxylases, which are essential in the formation of neurotransmitters, and for nitric oxide synthase. It is presently used clinically to treat some forms of phenylketonuria (PKU) that can be ameliorated by BH 4
Moens, An L., Kass, David A.
openaire   +3 more sources